Obstetrical & gynecological survey · 2025
Prevention of Venous Thromboembolism in Pregnancy and the Puerperium: A Comparative Review of Guidelines.
СтатьяОбзорСравнительное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Boureka Eirini, Arvanitaki Alexandra, Ralli Elpiniki-Elpida, Lefkou Eleftheria, Fragakis Nikolaos, Giannakoulas George, Eskitzis Panagiotis, Mamopoulos Apostolos, Dagklis Themistoklis, Tsakiridis Ioannis
Аннотация
IMPORTANCE: Venous thromboembolism (VTE), presenting either as deep vein thrombosis or as pulmonary embolism, is one of the leading causes of maternal morbidity and mortality.
OBJECTIVE: The aim of this study was to review and compare the most recently published international guidelines providing recommendations on the prevention of VTE in pregnancy and the puerperium.
EVIDENCE ACQUISITION: A comparative review of guidelines by the American College of Obstetricians and Gynecologists, the Royal College of Obstetricians and Gynecologists, the Royal Australian and New Zealand College of Obstetricians and Gynecologists, the Society of Obstetricians and Gynecologists of Canada, the American College of Chest Physicians, the European Society of Cardiology, and the American Society of Hematology on VTE was conducted.
RESULTS: There is an overall agreement among the reviewed guidelines regarding the optimal anticoagulation and dosage choice, the management of low-molecular-weight heparin relating to neuraxial blockade, the importance of implementing risk assessment scores in every individual, and certain indications for obstetric thromboprophylaxis. On the other hand, controversy exists regarding management of unfractionated heparin before and after regional anesthesia, cases where calf compression stockings are suitable and indications where thrombophilia screening is required. Moreover, discrepancies exist in relation to management strategies in women with specific inherited thrombophilias. Notably, specific risk assessment scores are presented only by the Royal College of Obstetricians and Gynecologists, the Royal Australian and New Zealand College of Obstetricians and Gynecologists, and the Society of Obstetricians and Gynecologists of Canada.
CONCLUSIONS: As VTE remains a significant factor affecting maternal morbidity and mortality, worldwide, developing consistent international algorithms is of utmost importance to safely guide clinical practice and consequently improve pregnancy outcomes.
OBJECTIVE: The aim of this study was to review and compare the most recently published international guidelines providing recommendations on the prevention of VTE in pregnancy and the puerperium.
EVIDENCE ACQUISITION: A comparative review of guidelines by the American College of Obstetricians and Gynecologists, the Royal College of Obstetricians and Gynecologists, the Royal Australian and New Zealand College of Obstetricians and Gynecologists, the Society of Obstetricians and Gynecologists of Canada, the American College of Chest Physicians, the European Society of Cardiology, and the American Society of Hematology on VTE was conducted.
RESULTS: There is an overall agreement among the reviewed guidelines regarding the optimal anticoagulation and dosage choice, the management of low-molecular-weight heparin relating to neuraxial blockade, the importance of implementing risk assessment scores in every individual, and certain indications for obstetric thromboprophylaxis. On the other hand, controversy exists regarding management of unfractionated heparin before and after regional anesthesia, cases where calf compression stockings are suitable and indications where thrombophilia screening is required. Moreover, discrepancies exist in relation to management strategies in women with specific inherited thrombophilias. Notably, specific risk assessment scores are presented only by the Royal College of Obstetricians and Gynecologists, the Royal Australian and New Zealand College of Obstetricians and Gynecologists, and the Society of Obstetricians and Gynecologists of Canada.
CONCLUSIONS: As VTE remains a significant factor affecting maternal morbidity and mortality, worldwide, developing consistent international algorithms is of utmost importance to safely guide clinical practice and consequently improve pregnancy outcomes.